Second-trimester multimetabolite panel for early preeclampsia rule-out

Area of Science:

• Biochemistry
• Clinical Chemistry
• Metabolomics

Background:

• Preeclampsia (PE) poses significant risks during pregnancy.
• Accurate early identification and exclusion of PE are crucial for effective management.
• Current screening methods require improvement in sensitivity and specificity.

Purpose of the Study:

• To develop a highly sensitive, multimetabolite model for ruling out preeclampsia.
• To minimize false negatives, enabling confident exclusion of low-risk pregnancies from intensive monitoring.

Main Methods:

• Prospective, nested case-control study design.
• Maternal serum samples collected between 20 and 26 weeks of gestation.
• Targeted metabolomics analysis of 41 metabolites using liquid chromatography-tandem mass spectrometry.

Main Results:

• Univariate analysis showed differences in methionine, glutamine, and threonine levels between PE cases and controls.
• A six-metabolite model achieved 100% sensitivity and 61% specificity for PE detection.
• The best model demonstrated a 100% negative predictive value.

Conclusions:

• The developed multimetabolite models show strong potential for ruling out preeclampsia.
• These models can aid in clinical decision-making and reduce healthcare system burden.
• Future application in gestational screening and monitoring strategies is promising.